Navigation Links
InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Date:9/2/2008

- $15 million development milestone payment to InterMune -

- Roche to lead ITMN-191 program in Phase 2 -

BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that InterMune has earned a $15 million development milestone under its development collaboration with Roche for the hepatitis C virus (HCV) NS3 protease inhibitor compound ITMN-191 (referred to as R7227 at Roche), currently in a Phase 1b clinical trial in combination with Pegasys(R) (peginterferon alfa-2a) and Copegus(R) (ribavirin).

Under the terms of their 2006 collaboration agreement, the clinical program for ITMN-191 is now being transitioned to Roche which, starting in Phase 2, will have primary responsibility for completing the global development and registration program.

Nick Cammack, Ph.D., Global Head of the Virology Disease Biology Area, Roche, said, "Protease inhibition is a crucial aspect of our HCV strategy, which is focused on developing clinically differentiated medicines for patients. Our continued enthusiasm for ITMN-191/R7227 underscores our confidence in InterMune and we now plan to rapidly move the program into Phase 2 development."

Dan Welch, Chairman, Chief Executive Officer and President of InterMune, said, "We are very pleased to have led the preclinical development, conducted three Phase 1 clinical trials and with Roche, optimized the manufacturing of ITMN-191 active pharmaceutical ingredient (API) since the collaboration was announced less than two years ago. We look forward to the continued strong relationship with Roche as we together develop protease inhibitor therapies in combination with current standard of care and with other direct antiviral agents."

<
'/>"/>
SOURCE InterMune, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. InterMune to Present at Thomas Weisel and Bear Stearns Healthcare Conferences
2. InterMune Announces Proposed Public Offering of Common Stock
3. InterMune Announces Pricing of $68 Million Public Offering of Common Stock
4. InterMune Announces Closing of Public Offering of Common Stock
5. InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance
6. InterMune to Present at the SIGnificant Options in Healthcare Conference
7. Evotec Expands Collaboration With InterMune
8. Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
9. InterMune to Present at Deutsche Bank Health Care Conference
10. InterMune to Present at Bank of America Health Care Conference
11. InterMune to Present at Citigroup Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... PORTLAND, Ore. , May 16, 2013 /PRNewswire/ ... to many of the nation,s largest regional health ... the America,s Health Insurance Plans (AHIP) Institute 2013 ... and highlight survey results showing how health insurance ... planning for the consumer and marketplace demands for ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
(Date:5/16/2013)... May 16, 2013 On average, developing ... over one billion dollars. Despite this investment, less than ... this high, is your clinical trial design optimally structured ... best outcomes? , Dr. Frederic Sax, Global Head of ... the use of data, information and technology in upfront ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ... MediPoint: Diagnostic Cardiac Biomarkers for ... and Market Forecasts ... Cardiac Biomarkers for Acute Coronary Syndromes ...
Breaking Biology Technology:HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
... Institute (PI), a leading provider of specialized training solutions for ... a new e-course titled, Introduction to Health Policy . ... Managed Markets Excellence(TM) series. The new ... of the challenges confronting the US healthcare system. ...
... Alliance, the leading management consulting firm specializing in the ... appointed industry veterans Jon W. McGarity and David Lilley ... directly with John Campbell, CEO of Campbell Alliance, and ... emerging and midsize client companies. They will focus ...
... SHANGHAI, June 17 /PRNewswire-Asia-FirstCall/ -- China-Biotics, ... a leading Chinese firm,specializing in the manufacture, research, ... it will join the Russell,3000(R) Index and Russell ... of U.S. and global equity indices on June,26, ...
Cached Biology Technology:Pharmaceutical Institute Launches New E-Course Focused on Health Policy 2Pharmaceutical Institute Launches New E-Course Focused on Health Policy 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 2Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 4China-Biotics, Inc. to Join Russell 3000 Index 2China-Biotics, Inc. to Join Russell 3000 Index 3
(Date:5/16/2013)... our pulses outside of the gym. But doctors use the ... , Zhenan Bao, a professor of chemical engineering at Stanford, ... and no wider than a postage stamp. The flexible skin-like ... sensitive enough to help doctors detect stiff arteries and cardiovascular ... continuously track heart health and provide doctors a safer method ...
(Date:5/16/2013)... May 16, 2013 The consultancy ... on Tuesday to Germany,s largest ... border control system. DERMALOG has been honored ... Practices Award in the category Global Biometrics and Border ... Biometric   Border Control System . One of ...
(Date:5/15/2013)... have powerful behavioral effects on diverse organisms often ... according to a theory proposed in the June ... the theory, Ryan P. Ferrer of Seattle Pacific ... of California at Los Angeles, liken such molecules ... be uncommon but exert a controlling influence, through ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... in the Indian Ocean and collaborating with researchers at the ... night cameras to capture the first known occurrence of a ... is this the first time this behaviour has been documented ... who are better known for eating plants but the ...
... COLLEGE STATION - Mango. If you know little about ... stop certain colon and breast cancer cells in the lab. ... AgriLife Research food scientists, who examined the five varieties most ... Though the mango is an ancient fruit heavily ...
... New standards to help ensure the quality and ... infant formulas and a variety of functional foods are ... (FCC), an internationally recognized compendium of quality standards for ... present in breast milk and commonly added to infant ...
Cached Biology News:First known instance of a cricket as an orchid pollinator captured on film by Kew scientist 2Mango effective in preventing, stopping certain colon, breast cancer cells 2Quality and safety of infant formulas, functional foods enhanced by new standards 2Quality and safety of infant formulas, functional foods enhanced by new standards 3
Rabbit polyclonal to CAMK 1D beta ( Abpromise for all tested applications). entrezGeneID: 57118 SwissProtID: Q5SQQ7...
Rabbit polyclonal to pCrosstide (HRP) ( Abpromise for all tested applications)....
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
ATGL Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: